Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy

S Kraler, MC Blaser, E Aikawa, GG Camici… - European heart …, 2022 - academic.oup.com
Calcific aortic valve disease (CAVD) is a highly prevalent condition that comprises a disease
continuum, ranging from microscopic changes to profound fibro-calcific leaflet remodelling …

Multi-omics approaches to define calcific aortic valve disease pathogenesis

MC Blaser, S Kraler, TF Lüscher, E Aikawa - Circulation research, 2021 - Am Heart Assoc
Calcific aortic valve disease sits at the confluence of multiple world-wide epidemics of aging,
obesity, diabetes, and renal dysfunction, and its prevalence is expected to nearly triple over …

Multiomics of tissue extracellular vesicles identifies unique modulators of atherosclerosis and calcific aortic valve stenosis

MC Blaser, F Buffolo, A Halu, ME Turner, F Schlotter… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: Fewer than 50% of patients who develop aortic valve calcification have
concomitant atherosclerosis, implying differential pathogenesis. Although circulating …

Innate and adaptive immunity: the understudied driving force of heart valve disease

F Bartoli-Leonard, J Zimmer… - Cardiovascular research, 2021 - academic.oup.com
Calcific aortic valve disease (CAVD), and its clinical manifestation that is calcific aortic valve
stenosis, is the leading cause for valve disease within the developed world, with no current …

Unraveling the mechanisms of valvular heart disease to identify medical therapy targets: a scientific statement from the American Heart Association

AM Small, KE Yutzey, BA Binstadt, K Voigts Key… - Circulation, 2024 - ahajournals.org
Valvular heart disease is a common cause of morbidity and mortality worldwide and has no
effective medical therapy. Severe disease is managed with valve replacement procedures …

Apolipoprotein C3 induces inflammasome activation only in its delipidated form

CC Hsu, B Shao, JE Kanter, Y He, T Vaisar… - Nature …, 2023 - nature.com
Increased levels of apolipoprotein C3 (APOC3) in the blood predict cardiovascular disease
risk in people with and without diabetes 1–4. Conversely, APOC3 loss-of-function variants …

APOC-III: a gatekeeper in controlling triglyceride metabolism

A Giammanco, R Spina, AB Cefalù… - Current Atherosclerosis …, 2023 - Springer
Abstract Purpose of Review Apolipoprotein C-III (ApoC-III) is a widely known player in
triglyceride metabolism, and it has been recently recognized as a polyhedric factor which …

The lipocalin apolipoprotein D functional portrait: a systematic review

D Sanchez, MD Ganfornina - Frontiers in Physiology, 2021 - frontiersin.org
Apolipoprotein D is a chordate gene early originated in the Lipocalin protein family. Among
other features, regulation of its expression in a wide variety of disease conditions in humans …

[HTML][HTML] Beyond VICs: Shedding light on the overlooked VECs in calcific aortic valve disease

L Fan, D Yao, Z Fan, T Zhang, Q Shen, F Tong… - Biomedicine & …, 2024 - Elsevier
Calcific aortic valve disease (CAVD) is prevalent in developed nations and has emerged as
a pressing global public health concern due to population aging. The precise etiology of this …

The complex relationship between hypoxia signaling, mitochondrial dysfunction and inflammation in calcific aortic valve disease: insights from the molecular …

E Bouhamida, G Morciano, G Pedriali… - International Journal of …, 2023 - mdpi.com
Calcific aortic valve stenosis (CAVS) is among the most common causes of cardiovascular
mortality in an aging population worldwide. The pathomechanisms of CAVS are such a …